_version_ 1784802287242182656
author Mungmunpuntipantip, Rujittika
Wiwanitkit, Viroj
author_facet Mungmunpuntipantip, Rujittika
Wiwanitkit, Viroj
author_sort Mungmunpuntipantip, Rujittika
collection PubMed
description
format Online
Article
Text
id pubmed-9533170
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Korean Society of Infectious Diseases; Korean Society for Antimicrobial Therapy; The Korean Society for AIDS
record_format MEDLINE/PubMed
spelling pubmed-95331702022-10-14 Regdanvimab Treatment of COVID-19 Mungmunpuntipantip, Rujittika Wiwanitkit, Viroj Infect Chemother Correspondence The Korean Society of Infectious Diseases; Korean Society for Antimicrobial Therapy; The Korean Society for AIDS 2022-09 2022-07-22 /pmc/articles/PMC9533170/ /pubmed/35920275 http://dx.doi.org/10.3947/ic.2022.0039 Text en Copyright © 2022 by The Korean Society of Infectious Diseases, Korean Society for Antimicrobial Therapy, and The Korean Society for AIDS https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Correspondence
Mungmunpuntipantip, Rujittika
Wiwanitkit, Viroj
Regdanvimab Treatment of COVID-19
title Regdanvimab Treatment of COVID-19
title_full Regdanvimab Treatment of COVID-19
title_fullStr Regdanvimab Treatment of COVID-19
title_full_unstemmed Regdanvimab Treatment of COVID-19
title_short Regdanvimab Treatment of COVID-19
title_sort regdanvimab treatment of covid-19
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533170/
https://www.ncbi.nlm.nih.gov/pubmed/35920275
http://dx.doi.org/10.3947/ic.2022.0039
work_keys_str_mv AT mungmunpuntipantiprujittika regdanvimabtreatmentofcovid19
AT wiwanitkitviroj regdanvimabtreatmentofcovid19